![Matthew Foster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Matthew Foster is currently the Chief Restructuring Officer at Allena Pharmaceuticals, Inc. since 2022.
Prior to this, he held the position of Chief Restructuring Officer at Argos Therapeutics, Inc.
Posizioni attive di Matthew Foster
| Società | Posizione | Inizio |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/09/2022 |
Precedenti posizioni note di Matthew Foster
| Società | Posizione | Fine |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
3
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Allena Pharmaceuticals, Inc.
 Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
